Tokyo Tape
Sign in
5% STAKE4594.TTSECAYMAN ISLANDS

Evo Fund lowers stake in BrightPath Biotherapeutics to 21.62%

Stake history

20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN21.62%Aug 26Aug 26: 21.62% · S100U9TY
20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN21.62%Aug 26Aug 26: 21.62% · S100U9TY

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-26 11:32 JST concerning BrightPath Biotherapeutics Co., Ltd. Reported holding ratio: 21.62%, previous report: 22.31%.

Stock price4594 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100U9TY ↗ · PDL1.0 · Not investment advice